Loading…
Reported covered position: U.S. Senate Committee on Health, Education, Labor and Pensions
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS via SL STRATEGIES, LLC
2026 · third_quarter · Q3
Warfighter readiness, specifically funding for musculoskeletal injuries in the military.
Fiscal Year 2027 DOD Appropriations bills, specifically the peer reviewed orthopaedic program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| PARTNER THERAPEUTICS | 9 | 2024–2026 |
| SEQIRUS | 9 | 2024–2026 |
| ALLIANCE FOR A STRONGER FDA | 8 | 2025–2026 |
| NATIONAL FOUNDATION FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION | 8 | 2025–2026 |
| UNIVERSITY OF TEXAS MEDICAL BRANCH | 7 | 2025–2026 |
| AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | 5 | 2025–2026 |
| GLOBAL HEALTH INVESTMENT CORPORATION | 3 | 2025–2026 |
| BAKER DONELSON (ON BEHALF OF THE DEANS NURSING POLICY COALITION) | 1 | 2024 |
| HELIX OPCO, LLC | 1 | 2024 |
2026 · third_quarter · Q3
Funding for biodefense, specifically within the National Institutes of Health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL FOUNDATION FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION via SL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to public health, including maternal health, measles, cancer, and policies impacting the Centers for Disease Control and Prevention and local public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR A STRONGER FDA via SL STRATEGIES, LLC
2026 · third_quarter · Q3
Fiscal Year 2027 Food and Drug Administration Appropriations
Resources related to the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARGENTUM MEDICAL DBA BRAVIDA MEDICAL via SL STRATEGIES, LLC
2026 · third_quarter · Q3
Policies impacting rad/nuc preparedness and response
Fiscal year 2027 appropriations for rad/nuc countermeasures within the HHS Strategic National Stockpile and Department of Defense.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
A1.9 STRATEGIES (ON BEHALF OF BATTELLE MEMORIAL INSTITUTE) via SL STRATEGIES, LLC
2026 · third_quarter · Q3
Biodefense preparedness and response; health care quality measurement; firefighter safety within NIOSH.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNER THERAPEUTICS via SL STRATEGIES, LLC
2026 · third_quarter · Q3
Issues related to rad/nuc preparedness and response.
Issues related to rad/nuc preparedness and response; Pandemic All-Hazards Preparedness and Response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via SL STRATEGIES, LLC
2026 · third_quarter · Q3
Fiscal Year 2027 HHS appropriations for seasonal and pandemic preparedness and response.
Policies related to seasonal and pandemic influenza preparedness and response. Pandemic All-Hazards Preparedness Act Reauthorization.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via SL STRATEGIES, LLC
2026 · third_quarter · Q3
Policies impacting the Defense Health Agencies military advanced surgical training and treatment (MAST) program
Fiscal Year 2027 Defense Health programmatic funding, specifically military advanced surgical training and treatment.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SEQIRUS via SL STRATEGIES, LLC
2026 · third_quarter · Q3
Fiscal Year 2027 HHS Appropriations bills
Policies impacting seasonal and pandemic influenza response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via SL STRATEGIES, LLC
2026 · third_quarter · Q3
Fiscal Year 2027 Appropriations bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC via SL STRATEGIES, LLC
2026 · third_quarter · Q3
Pandemic All Hazards Preparedness Act (PAHPA) reauthorization
Fiscal Year 2027 HHS Appropriations for Project BioShield Special Reserve Fund
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS via SL STRATEGIES, LLC
2026 · second_quarter · Q2
Warfighter readiness, specifically funding for musculoskeletal injuries in the military.
Fiscal Year 2027 DOD Appropriations bills, specifically the peer reviewed orthopaedic program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF TEXAS MEDICAL BRANCH via SL STRATEGIES, LLC
2026 · second_quarter · Q2
Funding for biodefense, specifically within the National Institutes of Health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL FOUNDATION FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION via SL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to public health, including maternal health, measles, cancer, and policies impacting the Centers for Disease Control and Prevention and local public health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR A STRONGER FDA via SL STRATEGIES, LLC
2026 · second_quarter · Q2
Fiscal Year 2027 Food and Drug Administration Appropriations
Resources related to the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARGENTUM MEDICAL DBA BRAVIDA MEDICAL via SL STRATEGIES, LLC
2026 · second_quarter · Q2
Fiscal year 2027 appropriations for rad/nuc countermeasures within the HHS Strategic National Stockpile and Department of Defense.
Policies impacting rad/nuc preparedness and response
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
A1.9 STRATEGIES (ON BEHALF OF BATTELLE MEMORIAL INSTITUTE) via SL STRATEGIES, LLC
2026 · second_quarter · Q2
Biodefense preparedness and response; health care quality measurement; firefighter safety within NIOSH.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNER THERAPEUTICS via SL STRATEGIES, LLC
2026 · second_quarter · Q2
Issues related to rad/nuc preparedness and response.
Issues related to rad/nuc preparedness and response; Pandemic All-Hazards Preparedness and Response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via SL STRATEGIES, LLC
2026 · second_quarter · Q2
Policies related to seasonal and pandemic influenza preparedness and response.
Fiscal Year 2027 HHS appropriations for seasonal and pandemic preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via SL STRATEGIES, LLC
2026 · second_quarter · Q2
Policies impacting the Defense Health Agencies military advanced surgical training and treatment (MAST) program
Fiscal Year 2027 Defense Health programmatic funding, specifically military advanced surgical training and treatment.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SEQIRUS via SL STRATEGIES, LLC
2026 · second_quarter · Q2
Policies impacting seasonal and pandemic influenza response
Fiscal Year 2027 HHS Appropriations bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via SL STRATEGIES, LLC
2026 · second_quarter · Q2
Fiscal Year 2027 Appropriations bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC via SL STRATEGIES, LLC
2026 · second_quarter · Q2
Fiscal Year 2027 HHS Appropriations for Project BioShield Special Reserve Fund
Pandemic All Hazards Preparedness Act (PAHPA) reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTH INVESTMENT CORPORATION via SL STRATEGIES, LLC
2026 · first_quarter · 1T
Support for reauthorization of the Biomedical Advanced Research and Development Authority
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS via SL STRATEGIES, LLC
2026 · first_quarter · Q1
Fiscal Year 2027 DOD Appropriations bills, specifically the peer reviewed orthopaedic program.
Warfighter readiness, specifically funding for musculoskeletal injuries in the military.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF TEXAS MEDICAL BRANCH via SL STRATEGIES, LLC
2026 · first_quarter · 1A
Funding for biodefense, specifically within the National Institutes of Health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNIVERSITY OF TEXAS MEDICAL BRANCH via SL STRATEGIES, LLC
2026 · first_quarter · Q1
Funding for biodefense, specifically within the National Institutes of Health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL FOUNDATION FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION via SL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to public health, including maternal health, measles, cancer, and policies impacting the Centers for Disease Control and Prevention.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR A STRONGER FDA via SL STRATEGIES, LLC
2026 · first_quarter · Q1
Fiscal Year 2027 Food and Drug Administration Appropriations
Resources related to the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARGENTUM MEDICAL DBA BRAVIDA MEDICAL via SL STRATEGIES, LLC
2026 · first_quarter · Q1
Policies impacting rad/nuc preparedness and response
Fiscal year 2027 appropriations for rad/nuc countermeasures within the HHS Strategic National Stockpile and Department of Defense.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
A1.9 STRATEGIES (ON BEHALF OF BATTELLE MEMORIAL INSTITUTE) via SL STRATEGIES, LLC
2026 · first_quarter · Q1
Biodefense preparedness and response; health care quality measurement; firefighter safety within NIOSH.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNER THERAPEUTICS via SL STRATEGIES, LLC
2026 · first_quarter · Q1
Issues related to rad/nuc preparedness and response.
Issues related to rad/nuc preparedness and response; Pandemic All-Hazards Preparedness and Response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via SL STRATEGIES, LLC
2026 · first_quarter · Q1
Policies related to seasonal and pandemic influenza preparedness and response.
Fiscal Year 2027 HHS appropriations for seasonal and pandemic preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via SL STRATEGIES, LLC
2026 · first_quarter · Q1
Fiscal Year 2027 Defense Health programmatic funding, specifically military advanced surgical training and treatment.
Policies impacting the Defense Health Agencies military advanced surgical training and treatment (MAST) program
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SEQIRUS via SL STRATEGIES, LLC
2026 · first_quarter · Q1
Policies impacting seasonal and pandemic influenza response
Fiscal Year 2027 HHS Appropriations bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via SL STRATEGIES, LLC
2026 · first_quarter · Q1
Fiscal Year 2027 Appropriations bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC via SL STRATEGIES, LLC
2026 · first_quarter · Q1
Fiscal Year 2027 HHS Appropriations for Project BioShield Special Reserve Fund
Pandemic All Hazards Preparedness Act (PAHPA) reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTH INVESTMENT CORPORATION via SL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Support for reauthorization of the Biomedical Advanced Research and Development Authority
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL HEALTH INVESTMENT CORPORATION via SL STRATEGIES, LLC
2025 · third_quarter · RR
Pandemic All Hazards and Preparedness Act reauthorization; Biomedical Advanced Research and Development Authority (BARDA) and support for the development of products and services to address health security.
Pandemic All Hazards and Preparedness Act reauthorization; Biomedical Advanced Research and Development Authority (BARDA) and support for the development of products and services to address health security.
Pandemic All Hazards and Preparedness Act reauthorization; Biomedical Advanced Research and Development Authority (BARDA) and support for the development of products and services to address health security.
AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS via SL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Fiscal Year 2026 DOD Appropriations bills, specifically the peer reviewed orthopaedic program.
Warfighter readiness, specifically funding for musculoskeletal injuries in the military.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF TEXAS MEDICAL BRANCH via SL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Funding for biodefense, specifically within the National Institutes of Health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL FOUNDATION FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION via SL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to public health, including maternal health, measles, cancer, and policies impacting the Centers for Disease Control and Prevention.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR A STRONGER FDA via SL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Fiscal Year 2026 Food and Drug Administration Appropriations
Resources related to the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARGENTUM MEDICAL DBA BRAVIDA MEDICAL via SL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Fiscal year 2026 appropriations for rad/nuc countermeasures within the HHS Strategic National Stockpile.
Policies impacting rad/nuc preparedness and response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
A1.9 STRATEGIES (ON BEHALF OF BATTELLE MEMORIAL INSTITUTE) via SL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Biodefense preparedness and response; health care quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNER THERAPEUTICS via SL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Issues related to rad/nuc preparedness and response; Pandemic All-Hazards Preparedness and Response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via SL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Fiscal Year 2026 HHS appropriations for seasonal and pandemic preparedness and response.
Policies related to seasonal and pandemic influenza preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via SL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Fiscal Year 2026 Defense Health Programmatic funding, specifically military advanced surgical training and treatment.
Military advanced surgical training and treatment.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SEQIRUS via SL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Fiscal Year 2026 HHS Appropriations bills
Policies impacting seasonal and pandemic influenza response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via SL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Fiscal Year 2026 Appropriations bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC via SL STRATEGIES, LLC
2025 · fourth_quarter · Q4
Fiscal Year 2026 HHS Appropriations for Project BioShield Special Reserve Fund
Pandemic All Hazards Preparedness Act (PAHPA) reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF TEXAS MEDICAL BRANCH via SL STRATEGIES, LLC
2025 · third_quarter · Q3
Funding for biodefense, specifically within the National Institutes of Health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL FOUNDATION FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION via SL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to public health, including maternal health, measles, cancer, and policies impacting the Centers for Disease Control and Prevention.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR A STRONGER FDA via SL STRATEGIES, LLC
2025 · third_quarter · Q3
Fiscal Year 2026 Food and Drug Administration Appropriations
Resources related to the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARGENTUM MEDICAL DBA BRAVIDA MEDICAL via SL STRATEGIES, LLC
2025 · third_quarter · Q3
Policies impacting rad/nuc preparedness and response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
A1.9 STRATEGIES (ON BEHALF OF BATTELLE MEMORIAL INSTITUTE) via SL STRATEGIES, LLC
2025 · third_quarter · Q3
Biodefense preparedness and response; health care quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNER THERAPEUTICS via SL STRATEGIES, LLC
2025 · third_quarter · Q3
Issues related to rad/nuc preparedness and response; Pandemic All-Hazards Preparedness and Response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via SL STRATEGIES, LLC
2025 · third_quarter · Q3
Fiscal Year 2026 HHS appropriations for seasonal and pandemic preparedness and response.
Policies related to seasonal and pandemic influenza preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via SL STRATEGIES, LLC
2025 · third_quarter · Q3
Fiscal Year 2026 Defense Health Programmatic funding, specifically military advanced surgical training and treatment.
Military advanced surgical training and treatment.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SEQIRUS via SL STRATEGIES, LLC
2025 · third_quarter · Q3
Fiscal Year 2026 HHS Appropriations bills
Policies impacting seasonal and pandemic influenza response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via SL STRATEGIES, LLC
2025 · third_quarter · Q3
Fiscal Year 2026 Appropriations bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC via SL STRATEGIES, LLC
2025 · third_quarter · Q3
Fiscal Year 2026 HHS Appropriations for Project BioShield Special Reserve Fund
Pandemic All Hazards Preparedness Act reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS via SL STRATEGIES, LLC
2025 · fourth_quarter · RR
FY26 Defense Appropriations bills
FY26 Defense Appropriations bills
UNIVERSITY OF TEXAS MEDICAL BRANCH via SL STRATEGIES, LLC
2025 · third_quarter · RR
Issues related to academic medical centers, research, science and technology policy, Medicaid and biodefense funding.
Issues related to academic medical centers, research, science and technology policy, Medicaid and biodefense funding.
Issues related to academic medical centers, research, science and technology policy, Medicaid and biodefense funding.
ALLIANCE FOR A STRONGER FDA via SL STRATEGIES, LLC
2025 · second_quarter · Q2
Fiscal Year 2025 and Fiscal Year 2026 Food and Drug Administration Appropriations
Resources related to the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL FOUNDATION FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION via SL STRATEGIES, LLC
2025 · second_quarter · Q2
Issues related to public health, including maternal health, measles, cancer, and policies impacting the Centers for Disease Control and Prevention.
Filing targets: HOUSE OF REPRESENTATIVES
ARGENTUM MEDICAL DBA BRAVIDA MEDICAL via SL STRATEGIES, LLC
2025 · second_quarter · Q2
Policies impacting rad/nuc preparedness and response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
A1.9 STRATEGIES (ON BEHALF OF BATTELLE MEMORIAL INSTITUTE) via SL STRATEGIES, LLC
2025 · second_quarter · Q2
Biodefense preparedness and response; health care quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNER THERAPEUTICS via SL STRATEGIES, LLC
2025 · second_quarter · Q2
Issues related to rad/nuc preparedness and response; Pandemic All-Hazards Preparedness and Response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via SL STRATEGIES, LLC
2025 · second_quarter · Q2
Fiscal Year 2026 HHS appropriations for seasonal and pandemic preparedness and response.
Policies related to seasonal and pandemic influenza preparedness and response.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via SL STRATEGIES, LLC
2025 · second_quarter · Q2
Fiscal Year 2026 Defense Health Programmatic funding, specifically military advanced surgical training and treatment.
Military advanced surgical training and treatment.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SEQIRUS via SL STRATEGIES, LLC
2025 · second_quarter · Q2
Fiscal Year 2026 HHS Appropriations bills
Response to the H5N1 influenza outbreak; policies impacting seasonal influenza response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via SL STRATEGIES, LLC
2025 · second_quarter · Q2
Fiscal Year 2026 Appropriations bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC via SL STRATEGIES, LLC
2025 · second_quarter · Q2
Fiscal Year 2026 HHS Appropriations for Project BioShield Special Reserve Fund
Pandemic All Hazards Preparedness Act reauthorization; Global mpox response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL FOUNDATION FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION via SL STRATEGIES, LLC
2025 · first_quarter · Q1
Public health
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARGENTUM MEDICAL DBA BRAVIDA MEDICAL via SL STRATEGIES, LLC
2025 · first_quarter · Q1
Rad/nuc preparedness and response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
A1.9 STRATEGIES (ON BEHALF OF BATTELLE MEMORIAL INSTITUTE) via SL STRATEGIES, LLC
2025 · first_quarter · Q1
Biodefense preparedness and response; health care quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNER THERAPEUTICS via SL STRATEGIES, LLC
2025 · first_quarter · Q1
Issues related to rad/nuc preparedness and response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION TO STOP FLU via SL STRATEGIES, LLC
2025 · first_quarter · Q1
Fiscal Year 2025 HHS appropriations for seasonal and pandemic preparedness and response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via SL STRATEGIES, LLC
2025 · first_quarter · Q1
Fiscal Year 2025 Defense Health Program funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SEQIRUS via SL STRATEGIES, LLC
2025 · first_quarter · Q1
Fiscal Year 2025 HHS Appropriations bills
Response to the H5N1 influenza outbreak
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via SL STRATEGIES, LLC
2025 · first_quarter · Q1
Fiscal Year 2025 Appropriations bills
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC via SL STRATEGIES, LLC
2025 · first_quarter · Q1
Fiscal Year 2025 HHS Appropriations for Project BioShield Special Reserve Fund
Pandemic All Hazards Preparedness Act reauthorization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL FOUNDATION FOR THE CENTERS FOR DISEASE CONTROL AND PREVENTION via SL STRATEGIES, LLC
2025 · first_quarter · RR
Public health issues; H5N1 and measles outbreak and response
ALLIANCE FOR A STRONGER FDA via SL STRATEGIES, LLC
2025 · first_quarter · Q1
Fiscal Year 2025 and Fiscal Year 2026 Food and Drug Administration Appropriations
Resources related to the Food and Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR A STRONGER FDA via SL STRATEGIES, LLC
2025 · first_quarter · RR
Fiscal Year 2025 Food and Drug Administration Appropriations
Fiscal Year 2025 Food and Drug Administration Appropriations
ARGENTUM MEDICAL DBA BRAVIDA MEDICAL via SL STRATEGIES, LLC
2024 · fourth_quarter · Q4
Preparedness for and against radiation/nuclear threats.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
A1.9 STRATEGIES (ON BEHALF OF BATTELLE MEMORIAL INSTITUTE) via SL STRATEGIES, LLC
2024 · fourth_quarter · Q4
Pandemic and All Hazards Preparedness Act reauthorization; gene synthesis; medical countermeasure Priority Review Voucher
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNER THERAPEUTICS via SL STRATEGIES, LLC
2024 · fourth_quarter · Q4
Issues related to radiation / nuclear events and preparedness for/against such threats.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION TO STOP FLU via SL STRATEGIES, LLC
2024 · fourth_quarter · Q4
Fiscal Year 2025 HHS Appropriations bills; provisions related to vaccine research, influenza surveillance and monitoring, research and development of medical countermeasures.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARTHROSCOPY ASSOCIATION OF NORTH AMERICA via SL STRATEGIES, LLC
2024 · fourth_quarter · Q4
Fiscal Year 2025 Defense Appropriations bills, specifically provisions related to the Defense Health Agency training for orthopedic surgery
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via SL STRATEGIES, LLC
2024 · fourth_quarter · 4A
Fiscal Year 2025 Appropriations bills, specifically provisions related to the biopharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES
BAVARIAN NORDIC via SL STRATEGIES, LLC
2024 · fourth_quarter · 4A
Biodefense; Pandemic All Hazards Preparedness Act Reauthorization; Mpox Response
Fiscal Year 2025 HHS Appropriations bills, specific provisions related to biodefense and mpox outbreak funding.
Filing targets: HOUSE OF REPRESENTATIVES
SEQIRUS via SL STRATEGIES, LLC
2024 · fourth_quarter · Q4
Pandemic All Hazards Preparedness Act reauthorization; policies impacting preparedness for and response to seasonal and pandemic influenza
Fiscal Year 2025 HHS Appropriations bills; specifically provisions related to seasonal influenza and H5N1 pandemic response.
Filing targets: HOUSE OF REPRESENTATIVES
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via SL STRATEGIES, LLC
2024 · fourth_quarter · Q4
Fiscal Year 2025 Appropriations bills, specifically provisions related to the biopharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAVARIAN NORDIC via SL STRATEGIES, LLC
2024 · fourth_quarter · Q4
Biodefense; Pandemic All Hazards Preparedness Act Reauthorization; Mpox Response
Fiscal Year 2025 HHS Appropriations bills, specific provisions related to biodefense and mpox outbreak funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARGENTUM MEDICAL DBA BRAVIDA MEDICAL via SL STRATEGIES, LLC
2024 · third_quarter · Q3
Preparedness for and against radiation/nuclear threats.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
A1.9 STRATEGIES (ON BEHALF OF BATTELLE MEMORIAL INSTITUTE) via SL STRATEGIES, LLC
2024 · third_quarter · Q3
Pandemic and All Hazards Preparedness Act reauthorization; gene synthesis; medical countermeasure Priority Review Voucher
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PARTNER THERAPEUTICS via SL STRATEGIES, LLC
2024 · third_quarter · Q3
Issues related to radiation / nuclear events and preparedness for/against such threats.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Pandemic All Hazards and Preparedness Act reauthorization; Biomedical Advanced Research and Development Authority (BARDA) and support for the development of products and services to address health security.
Issues related to academic medical centers, research, science and technology policy, Medicaid and biodefense funding.
Issues related to academic medical centers, research, science and technology policy, Medicaid and biodefense funding.